Cargando…
Phytic acid-modified CeO(2) as Ca(2+) inhibitor for a security reversal of tumor drug resistance
Ca(2+) plays critical roles in the development of diseases, whereas existing various Ca regulation methods have been greatly restricted in their clinical applications due to their high toxicity and inefficiency. To solve this issue, with the help of Ca overexpressed tumor drug resistance model, the...
Autores principales: | Tian, Zhimin, Zhao, Junlong, Zhao, Shoujie, Li, Huicheng, Guo, Zhixiong, Liang, Zechen, Li, Jiayuan, Qu, Yongquan, Chen, Dongfeng, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tsinghua University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800414/ https://www.ncbi.nlm.nih.gov/pubmed/35126877 http://dx.doi.org/10.1007/s12274-022-4069-0 |
Ejemplares similares
-
Insights on catalytic mechanism of CeO(2) as multiple nanozymes
por: Ma, Yuanyuan, et al.
Publicado: (2022) -
Dual-responsive dithio-polydopamine coated porous CeO(2) nanorods for targeted and synergistic drug delivery
por: Zhang, Ying, et al.
Publicado: (2018) -
Ce=O Terminated CeO(2)
por: Grinter, David C., et al.
Publicado: (2021) -
Efficient electroreduction of CO(2) to C(2+) products on CeO(2) modified CuO
por: Yan, Xupeng, et al.
Publicado: (2021) -
The activity and stability of CeO(2)@CaO catalysts for the production of biodiesel
por: Zhang, Ni, et al.
Publicado: (2018)